- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04729894
Evaluating the Impact of a Safe Medication Storage Device
Evaluating the Impact of a Safe Medication Storage Device on Modifiable Storage Behaviors and Pediatric Poisonings
Despite the initial success of the 1970s Poison Prevention Packaging Act, the incidence of pediatric medication poisonings in the United States remains high. Unintentional pediatric medication ingestions result in significant morbidity and are associated with substantial healthcare use and costs. A majority of these medication poisonings involve a caregivers' medication and are caused by modifiable unsafe storage behaviors. A better understanding of factors associated with pediatric poisonings and safe medication storage behaviors is needed to inform public health policy and develop targeted educational interventions. Furthermore, low-cost, scalable interventions that improve medication storage behaviors and reduce pediatric poisonings are necessary to address this ongoing preventable public health crisis.
In preliminary experiments, a baseline evaluation of caregivers demonstrated that they are unlikely to have a locked medication storage device in their home, but would be willing to use a locked device if one was available. Additionally, a follow-up assessment indicated that a majority of caregivers had used their medication over a one-month period. The latter feasibility assessment supports both caregiver willingness to use a safe storage device and demonstrates that a storage device can improve medication storage behaviors in the short-term.
Given these findings, we hypothesize that pediatric medication poisonings are due to improper storage, that medication storage behaviors are influenced by demographic and household specific factors, and that medication lockboxes improve safe medication storage behaviors and reduce pediatric poisonings. These hypotheses will be evaluated using the studies in the following Specific Aims: (1) to identify factors associated with pediatric poisonings, (2) to identify factors associated with medication storage behaviors, (3) to evaluate the effect of lockboxes on storage behaviors and pediatric poisonings.
Should this exploratory study reveal factors associated with increased risk for pediatric poisoning or with safe medication storage, and should safe medication storage interventions improve modifiable storage behaviors or show a reduction in pediatric poisonings, the results will be used to inform targeted public health campaigns and to develop a low-cost, scalable national program for improving safe medication storage and reducing pediatric poisonings.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: William Eggleston, PharmD
- Phone Number: 607-777-5848
- Email: wegglest@binghamton.edu
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Primary caregivers of pediatric patients less than 6 years of age presenting to the emergency department
- Adults (at least 18 years of age) who are responsible for supervising at least one child under the age of 6 years in their residence
- Supervision of at least one child under the age of 6 years for at least 3.5 days per week on average
Exclusion Criteria:
- pediatric patients who are critically ill or unstable
- pediatric patients presenting due to a poisoning related incident
- caregivers who are unable or unwilling to provide consent
- caregivers who are non-English speaking.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Education
|
Participants will receive information on safe medication storage practices.
|
|
Experimental: Safe Medication Storage Device + Education
|
Participants will receive a medication lockbox to store medications in their home.
Participants will receive information on safe medication storage practices.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Medication Storage Behaviors
Time Frame: 1 year
|
Participants will be evaluated at regular intervals over a one year period to evaluate the impact of a medication box + education, compared to education alone, on their short and long-term medication storage behaviors.
These storage behaviors include storage location in the home, storage device(s), storage location height, co-storage with non-medication items, and alternative storage locations.
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pediatric Poisonings
Time Frame: 1 year
|
The rate of pediatric poisonings will be evaluated within each group and compared.
|
1 year
|
|
Medication Adherence
Time Frame: 1 year
|
Household medication adherence will be evaluated within each group and compared.
Adherence will be measured using the validated eight-item Morisky Medication Adherence Scale (MMAS-8).
|
1 year
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY00002619
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Poisoning
-
National Institute of Environmental Health Sciences...Health Canada; Danish Institute for Public Health; Indian and Northern Affairs...Completed
-
National Institute of Environmental Health Sciences...Completed
-
Sir Salimullah Medical College Mitford HospitalCompletedOrganophosphorus PoisoningBangladesh
-
Rigshospitalet, DenmarkCompletedCarbon Monoxide Poisoning From Fire AccidentsDenmark
-
Intermountain Health Care, Inc.Recruiting
-
University of EdinburghToxicology Society of BangladeshCompletedPesticide Poisoning | Anticholinesterase Insecticide PoisoningBangladesh
-
Intermountain Health Care, Inc.Enrolling by invitation
-
Amani Hassan Abdel-WahabWithdrawnOrganophosphorus Poisoning
-
Ain Shams UniversityRecruiting
-
St George's, University of LondonUniversity College, LondonUnknownCarbon Monoxide Poisoning
Clinical Trials on Medication Lockbox
-
Joke WuytsAssociation of Belgian Pharmacies (APB)Completed
-
University of TennesseeKali Care; Barney's Pharmacy; Creative Care Pharmacy; Hutton Pharmacy; Mustang DrugTerminated
-
Samsung Medical CenterNot yet recruitingAcute Myocardial Infarction | InsominaSouth Korea
-
Diakonhjemmet HospitalUniversity of Oslo; Diakonhjemmet Hospital Pharmacy; Diakonhjemmet FoundationCompletedDrug-Related Side Effects and Adverse Reactions | Drug Interaction Potentiation | Medication Compliance | Remission | Medicinal Substance; Adverse EffectNorway
-
Cairo UniversityRecruitingAerobic Versus Resistive Intradialytic Training Effect on Atherogeinc Index in Hemodialysis PatientsChronic Kidney Disease Requiring HemodialysisEgypt
-
Wayne SandersonCompletedMedication Adherence | Health Behavior | Understanding of Medication InstructionsUnited States
-
McMaster UniversityCanadian Institutes of Health Research (CIHR); David Braley and Nancy Gordon... and other collaboratorsCompletedPolypharmacy | Multi-morbidity | Medication Therapy ManagementCanada
-
McMaster UniversityCanadian Institutes of Health Research (CIHR); David Braley and Nancy Gordon... and other collaboratorsRecruitingPolypharmacy | Multi-morbidity | Medication Therapy ManagementCanada
-
University of North Texas Health Science CenterUniversity of California, San Francisco; University of Minnesota; Walgreens Boots...TerminatedHypertension | Diabetes Mellitus, Type 2 | HIV/AIDSUnited States
-
Aalborg University HospitalCompletedGraves Disease | Hyperthyroidism